Immediate Impact
53 standout
Citing Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2021 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Works of Tim Prieur being referenced
Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography
1996
Aortic regurgitation: A common complication after surgery for hypertrophic obstructive cardiomyopathy
1989
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tim Prieur | 147 | 489 | 126 | 153 | 5 | 609 | |
| Jacques Pariès | 146 | 274 | 142 | 114 | 11 | 607 | |
| Ray Nelson | 68 | 364 | 91 | 60 | 6 | 659 | |
| Jan F. Nauta | 55 | 512 | 175 | 97 | 14 | 677 | |
| Evelien E.S. van Riet | 70 | 571 | 84 | 57 | 6 | 720 | |
| Ramesh de Silva | 46 | 569 | 95 | 180 | 11 | 727 | |
| John Ratcliff | 47 | 527 | 57 | 251 | 5 | 562 | |
| Rosaleen Boswell | 56 | 437 | 137 | 187 | 12 | 527 | |
| David G. Hurrell | 105 | 538 | 162 | 160 | 15 | 610 | |
| Benjamin J. Freda | 86 | 333 | 131 | 117 | 11 | 580 | |
| Kim P. Wagenaar | 60 | 510 | 68 | 44 | 7 | 611 |
All Works
Loading papers...